1 / 5

DUE DILIGENCE IN PHARMACEUTICAL INDUSTRY

Due Diligence (DD) is the formalized process of defining a potential business suitability for pharma companies. Knors Pharma is the best due diligence services provider for pharma companies in the investigation of a potential investment or acquisition. It is the act of evaluating the risk associated with a particular transaction

knorsphrma
Download Presentation

DUE DILIGENCE IN PHARMACEUTICAL INDUSTRY

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Due Diligence in Pharmaceutical Industry

  2. Due diligence in Pharmaceutical Industryis the thorough review and assessment of a potential asset to determine the asset’s viability (unknowns, benefits, and risks).  Due diligence involves a detailed review of available data, relevant regulations, and Literature to guide informed licensing decisions and negotiations.  As the pharmaceutical industry reaches record numbers of acquisitions in recent years, the challenges of acquiring assets are sure to be present.

  3. Why Choose KnorsPharma Solutions for Regulatory Due Diligence in Pharmaceutical Industry ? • Help identifying Project Engineering Consultants for the new R&D facility • Support identifying a right partner for your requirements of Formulation Development including parenteral. • Guidance for Contract Manufacturing and R&D space for Pharmaceuticals • Evaluate process parameters for manufacturing from a compliance perspective.

  4. Regulatory Affairs Due Diligence KnorsPharma approach to regulatory affairs is to match regulatory expertise with scientific, clinical, nonclinical, and overall drug development expertise to support marketing approval and market acceptance. KnorsPharma team of regulatory affairs professionals understand the statutes, key regulatory opinions, and procedures that make for successful interactions with regulatory authorities like the FDA. However, we also realize that this expertise is not enough. Equally important is the ability to generate well-written and succinct arguments that are grounded in proven scientific, regulatory, and overall drug development principles.

  5. CONTACT US www.knorspharma.com +91-9878880408, 0162-351544 knorspharma@gmail.com

More Related